Hopes rising at Bod Science over commercial prospects for Aqua Phase by Steve Jones May 23, 2023April 30, 2024 Bod Science has received ethics approval for a second pharmacokinetics (PK) study that will test the […]
Bod medical sales fall as demand continues for high-THC products by Steve Jones May 1, 2023April 30, 2024
Company news: Cann Global; Elixinol; Bod Science; AusCann; IvyMed Clinic; Botanix by Steve Jones and Martin Lane April 5, 2023April 30, 2024
Bod Science submits ethics approval for bioavailability study by Steve Jones March 28, 2023April 30, 2024
Bod CEO ‘confident’ firm will register over-the-counter CBD medicine as insomnia trial progresses by Martin Lane March 13, 2023April 30, 2024
Bod Science clears stability hurdle for Aqua Phase deal but PK study delayed by Steve Jones March 7, 2023April 30, 2024
Rise of THC flower hits Bod CBD sales as medical revenues fall 29% by Steve Jones February 27, 2023April 30, 2024
Company news: Avecho; Levin Health; Cannatrek; Releaf Group; Bod Science by Martin Lane and Steve Jones December 22, 2022April 29, 2024
Bod changes name to reflect focus on drug development and innovation by Steve Jones December 14, 2022April 29, 2024
